We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000080:KRXHITEJINRO Co., Ltd. Analysis

Data as of 2026-07-16 - not real-time

₩14,910.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

HITEJINRO’s stock is currently trading just above its short‑term moving average while remaining under the longer‑term averages, indicating a mixed technical picture. The RSI sits in the middle range, suggesting neither extreme buying nor selling pressure, yet the MACD histogram has turned positive, hinting at a tentative bullish shift. Volume has been weakening, and the recent price action is confined between a clear support zone and a modest resistance level, underscoring a fragile short‑term outlook. Volatility remains elevated, and beta is low, meaning price swings are more company‑specific than market‑driven. The discounted cash flow model points to a fair value far below today’s price, highlighting a substantial overvaluation. Fundamentally, revenue is contracting and margins are modest, while debt levels are high relative to equity, raising concerns about financial resilience. No dividend is being paid, which limits income‑focused appeal. The consumer defensive sector offers some defensive cushion, but regulatory scrutiny on alcoholic beverages adds a layer of uncertainty.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • price is near a key support level with weakening volume
  • valuation gap between market price and intrinsic estimate
  • high volatility and bearish technical bias

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • defensive consumer sector provides stability
  • ongoing earnings pressure from declining revenue
  • potential for modest recovery if cost discipline improves

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • brand strength in a staple beverage market
  • persistent overvaluation limiting upside
  • structural debt load may constrain long‑term growth

Key Metrics & Analysis

Financial Health

Revenue Growth-3.60%
Profit Margin1.59%
P/E Ratio9.5
ROE3.39%
ROA3.03%
Debt/Equity90.36
Op. Cash Flow₩259.6B
Free Cash Flow₩69.0B

Technical Analysis

TrendBearish
RSI45.2
Support₩13,830.00
Resistance₩15,690.00
MA 20₩14,903.00
MA 50₩15,801.00
MA 200₩17,497.30
MACDBullish
VolumeDecreasing
Fear & Greed Index91.55

Valuation

Fair Value₩3,295.59
Target Price₩21,750.00
Upside/Downside45.88%
GradeOvervalued
TypeValue

Risk Assessment

Beta0.20
Volatility32.11%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.